Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jumpei Morita"'
Autor:
Masako Yokota, Yukiho Kobayashi, Jumpei Morita, Hiroyuki Suzuki, Yoshihide Hashimoto, Yoshihiro Sasaki, Kazunari Akiyoshi, Keiji Moriyama
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101693 (2014)
Apert syndrome is an autosomal dominantly inherited disorder caused by missense mutations in fibroblast growth factor receptor 2 (FGFR2). Surgical procedures are frequently required to reduce morphological and functional defects in patients with Aper
Externí odkaz:
https://doaj.org/article/337958229cf14b40b0911c6afc15223a
Autor:
Michio Otsuki, Jumpei Morita
Publikováno v:
The European physical journal. E, Soft matter. 44(8)
We numerically investigate the stress distribution of a paste when an external oscillation is applied. The paste memorizes the oscillation through plastic deformation. Due to the plastic deformation, the residual stress remains after the oscillation,
Autor:
Tsukasa Watanabe, Kojiro Yamaji, Momotoshi Shiga, Jumpei Morita, Kentaro Ono, Kaori Gunjigake, Tatsuo Kawamoto, Mitsushiro Nakatomi, Keiji Moriyama
Publikováno v:
Developmental Dynamics. 247:1175-1185
Background Apert syndrome is characterized by craniosynostosis and bony syndactyly of the hands and feet. The cause of Apert syndrome is a single nucleotide substitution mutation (S252W or P253R) in fibroblast growth factor receptor 2 (FGFR2). Clinic
Autor:
Kojiro, Yamaji, Jumpei, Morita, Tsukasa, Watanabe, Kaori, Gunjigake, Mitsushiro, Nakatomi, Momotoshi, Shiga, Kentaro, Ono, Keiji, Moriyama, Tatsuo, Kawamoto
Publikováno v:
Developmental dynamics : an official publication of the American Association of Anatomists. 247(11)
Apert syndrome is characterized by craniosynostosis and bony syndactyly of the hands and feet. The cause of Apert syndrome is a single nucleotide substitution mutation (S252W or P253R) in fibroblast growth factor receptor 2 (FGFR2). Clinical experien
Publikováno v:
European journal of orthodontics. 39(3)
Background and objectives Relaxin (RLN) is an insulin-like hormone associated with extracellular matrix degradation, osteoclastogenesis, and osteoblast differentiation. This study aimed to assess the effect of RLN during and after lateral expansion o
Autor:
Jumpei Morita, Yoshiro Matsui, Toshinori Iwai, Shihomi Shoji, Makoto Adachi, Takafumi Fukui, Kei Watanuki, Kenji Mitsudo, Iwai Tohnai
Publikováno v:
Journal of Japan Society for Oral Tumors. 20:151-156
Autor:
Yoshihiro Sasaki, Keiji Moriyama, Kazunari Akiyoshi, Yoshihide Hashimoto, Yukiho Kobayashi, Jumpei Morita, Hiroyuki Suzuki, Masako Yokota
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101693 (2014)
PLoS ONE
PLoS ONE
Apert syndrome is an autosomal dominantly inherited disorder caused by missense mutations in fibroblast growth factor receptor 2 (FGFR2). Surgical procedures are frequently required to reduce morphological and functional defects in patients with Aper
Autor:
Chu-Xia Deng, Masataka Nakamura, Keiji Moriyama, Jumpei Morita, Noriko Funato, Yukiho Kobayashi
Publikováno v:
Developmental dynamics : an official publication of the American Association of Anatomists. 243(4)
Background: Apert syndrome (AS) is characterized by craniosynostosis, midfacial hypoplasia, and bony syndactyly. It is an autosomal dominantly inherited disease caused by point mutations (S252W or P253R) in fibroblast growth factor receptor (FGFR) 2.
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(13)
1,N(6)-Ethenoadenosine derivatives have been applied as fluorescence probes in various fields of biochemistry and molecular biology. We developed a 1,N(6)-ethenoadenosine-forming reaction at a target adenine in DNA duplex and applied it to a mutation
Publikováno v:
European Journal of Orthodontics; Jun2017, Vol. 39 Issue 3, p227-234, 8p